Sulthiame shows promise in reducing obstructive sleep apnea symptoms

Patients taking sulthiame, a drug currently in use for epilepsy, experienced a reduction in their symptoms of obstructive sleep apnoea (OSA), according to results of a clinical trial presented at the European Respiratory Society (ERS) Congress in Vienna, Austria.

Pluri launches manufacturing division as cell therapy pipeline progresses – Pharmaceutical Technology

Share this article In an exclusive interview with Pharmaceutical Technology, Pluri’s CEO Yaki Yanay discussed the company’s recent contract manufacturing expansion. Credit: MagioreStock via Shutterstock.

April 8, 2024

Unprecedented brain cell mapping sheds light on Alzheimer’s

Less than a decade ago, when Dr. Hansruedi Mathys launched an ambitious project to create an annotated library of all the gene readouts stored within

July 25, 2024

Northwestern Deploys Epic-Integrated DAX Copilot

What You Should Know: – Nuance Communications, a Microsoft company, announced that Northwestern Medicine has selected Dragon Ambient eXperience (DAX) Copilot as its ambient voice

August 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.